Skip Navigation
Menu Search
Pediatric Oncology

In This Section      

The Pratilas Laboratory

Pratilas Lab Staff

Our lab focuses on the application of small molecule therapeutics to solid tumors harboring oncogenic activation of RAS and RAS effector pathways. We emphasize interrogation of biochemical and adaptive signaling responses to small molecule inhibition of RAF and MEK kinases, to identify factors that predict and condition response to targeted therapeutics.

Our current projects:

Latest News:

AACR Abstracts:

Our Lab's Discoveries:

Other Recent Publications from Christine Pratilas: